🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I can find large conferences harder to navigate than smaller, more specific ones. What would be your top tips? Here's a 2-min reflection after ASTMH #TropMed24. Could also mention preparing 1-min elevator pitches to summarise your work & dressing for arctic A/C! #AtTheEquatorUG

#DOLPHIN3 #AMR #AntimicrobialResistance #AtTheEquatorUG

The lack of access to LAI cabotegravir–rilpivirine for treatment and research in Africa impacts research and future implementation of LAI-ART. SDG 3.8 specifies access to safe, effective, quality, and affordable essential medicines and vaccines for all. thelancet.com/journals/lanhi…

#BeatNTDs #DOLPHIN3

#BeatNTDs #DOLPHIN3

#IDWGS2025 #WomenInScience #GirlsInScience #WomenInSTEM #HerVoiceInScience #AtTheEquatorUG

#IDWGS2025 #WomenInScience #GirlsInScience #WomenInSTEM #HerVoiceInScience #AtTheEquatorUG

#IDWGS2025 #WomenInScience #GirlsInScience #WomenInSTEM #HerVoiceInScience #DOLPHIN3

#IDWGS2025 #WomenInScience #GirlsInScience #WomenInSTEM #HerVoiceInScience #DOLPHIN3

STEM. #IDWGS2025 #WomenInScience #GirlsInScience #WomenInSTEM #HerVoiceInScience #DOLPHIN3

#IDWGS2025 #WomenInScience #GirlsInScience #WomenInSTEM #HerVoiceInScience #AtTheEquatorUG

#IDWGS2025 #WomenInScience #GirlsInScience #WomenInSTEM #HerVoiceInScience #AtTheEquatorUG

#IDWGS2025 #WomenInScience #GirlsInScience #WomenInSTEM #HerVoiceInScience #AtTheEquatorUG

A day of learning, collaboration, and insights! From research design to implementation strategies, the #WISHStudy team is equipped and ready to hit the field. Catriona Waitt Simon Peter Asiimwe🌍 🇺🇬 ritah Semakula Jacqueline Kyeyune Mr.MAGOOLA stonekamoga Disability Rights UK European Disability Forum NUDIPU

Our Uganda Principal Investigator Prof. Catriona Waitt shared exciting updates on the significant progress on the DOLPHIN3 study. During the CAB meeting, she highlighted steps taken in getting the study approvals. #DOLPHIN3 #ResearchUpdate #HealthInnovation

He is Risen! The Drug Optimisation in LMIC of Pregnant HIV Women and Their INfants: Temporary Switch to CAB/RPV Long-Acting Injections (DolPHIN-3) study team wishes you a blessed and joyful Easter. #HappyEaster #DOLPHIN3 #AtTheEquatorUG

#EDCTPForum pre-event showcases innovation, progress, partnership and excellence in Rwanda over the past 30 years. Albert Tuyishime Director General of Rwanda Biomedical Centre shares learning and ongoing priorities. Global Health EDCTP3

#EDCTPForum current and emerging disease threats summarised eloquently by John Amusai. Much has been achieved, but we still need to harness all our strength and partnerships to tackle the current landscape! #AtTheEquatorUG Global Health EDCTP3

#DOLPHIN3 #EDCTPForum #AtTheEquatorUG

#DOLPHIN3 #EDCTPForum #AtTheEquatorUG